[go: up one dir, main page]

IL123293A - Piperidine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Piperidine derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL123293A
IL123293A IL12329396A IL12329396A IL123293A IL 123293 A IL123293 A IL 123293A IL 12329396 A IL12329396 A IL 12329396A IL 12329396 A IL12329396 A IL 12329396A IL 123293 A IL123293 A IL 123293A
Authority
IL
Israel
Prior art keywords
piperidine derivatives
preparation
pharmaceutical compositions
compositions containing
derivatives
Prior art date
Application number
IL12329396A
Other languages
English (en)
Other versions
IL123293A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL123293A0 publication Critical patent/IL123293A0/xx
Publication of IL123293A publication Critical patent/IL123293A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL12329396A 1995-09-07 1996-08-29 Piperidine derivatives, their preparation and pharmaceutical compositions containing them IL123293A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH254895 1995-09-07
CH187696 1996-07-26
PCT/EP1996/003803 WO1997009311A1 (fr) 1995-09-07 1996-08-29 Nouvelles 4-(oxyalcoxyphenyl)-3-oxy-piperidines utiles pour traiter l'insuffisance cardiaque et renale

Publications (2)

Publication Number Publication Date
IL123293A0 IL123293A0 (en) 1998-09-24
IL123293A true IL123293A (en) 2003-06-24

Family

ID=25688898

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12329396A IL123293A (en) 1995-09-07 1996-08-29 Piperidine derivatives, their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (2) US6051712A (fr)
EP (1) EP0863875B1 (fr)
JP (1) JP3648251B2 (fr)
KR (1) KR100384979B1 (fr)
CN (1) CN1256326C (fr)
AT (1) ATE242213T1 (fr)
BR (1) BR9610385A (fr)
CA (1) CA2230931C (fr)
CY (1) CY2488B1 (fr)
CZ (1) CZ292327B6 (fr)
DE (1) DE59610509D1 (fr)
DK (1) DK0863875T3 (fr)
ES (1) ES2201192T3 (fr)
HK (1) HK1016177A1 (fr)
HU (1) HUP9900926A3 (fr)
IL (1) IL123293A (fr)
MA (1) MA23967A1 (fr)
MY (1) MY121967A (fr)
NO (1) NO310069B1 (fr)
NZ (1) NZ315677A (fr)
PL (1) PL193686B1 (fr)
PT (1) PT863875E (fr)
RU (1) RU2167865C2 (fr)
SA (1) SA96170317B1 (fr)
TR (1) TR199800409T1 (fr)
TW (1) TW474932B (fr)
WO (1) WO1997009311A1 (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221921B1 (hu) 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
AU7206398A (en) 1997-05-14 1998-12-08 Neurosearch A/S Piperidine derivatives as neurotransmitter re-uptake inhibitors
JP2002514222A (ja) 1997-05-29 2002-05-14 スミスクライン・ビーチャム・コーポレイション 新規方法
WO1999012532A2 (fr) * 1997-09-08 1999-03-18 F.Hoffmann-La Roche Ag Derives de piperidine contre la malaria
AR015269A1 (es) 1998-04-10 2001-04-18 Japan Tobacco Inc Compuesto amidinico y composicion farmaceutica, inhibidor de la coagulacion sanguinea e inhibidor del factor xa que lo comprenden
US6268499B1 (en) * 1998-08-10 2001-07-31 Hoffman-La Roche Inc. Process and intermediates for preparation of substituted piperidine-epoxides
US6274735B1 (en) 1998-08-10 2001-08-14 Hoffmann-La Roche Inc. Process and intermediates for preparation of substituted piperidines
WO2000063173A1 (fr) * 1999-04-14 2000-10-26 F. Hoffmann-La Roche Ag Procede de preparation de piperidines substituees
US6197959B1 (en) 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
EP1214303A1 (fr) * 1999-08-31 2002-06-19 Merck & Co., Inc. Composes heterocycliques et procedes d'utilisation de ceux-ci
CZ20021663A3 (cs) 1999-10-15 2002-09-11 F. Hoffmann-La Roche Ag Nové deriváty benzodiazepinu
HUP0300649A3 (en) * 2000-06-13 2003-10-28 Basf Ag Fungicidal 5-phenyl substituted 2-(cyanoamino)pyrimidines, preparation and use thereof
WO2002076440A2 (fr) * 2001-03-23 2002-10-03 Elan Pharmaceuticals, Inc. Methodes de traitement de la maladie d'alzheimer
CA2467749A1 (fr) 2001-11-19 2003-05-30 Elan Pharmaceuticals, Inc. Piperidines et piperazines 3,4-disubstituees, 3,5-disubstituees et 3,4,5-substituees
CN1649870A (zh) * 2002-04-29 2005-08-03 埃科特莱茵药品有限公司 7－芳基－3,9－二氮杂双环[3.3.1]壬－6－烯衍生物及其在治疗高血压,心血管或肾疾病中作为肾素抑制剂的应用
AU2003229746A1 (en) * 2002-06-27 2004-01-19 Actelion Pharmaceuticals Ltd Novel tetrahydropyridine derivatives as renin inhibitors
CN1964630A (zh) 2003-02-13 2007-05-16 耶希瓦大学艾伯塔·爱恩斯坦医学院 通过控制下丘脑的长链脂肪酰基－辅酶A(LC－CoA)的水平来调控食物摄取和葡萄糖产生
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
US20060217371A1 (en) * 2003-04-28 2006-09-28 Olivier Bezencon Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors
CA2521932A1 (fr) * 2003-04-29 2004-11-11 Actelion Pharmaceuticals Ltd Nouveaux derives de la 1,2,3,6-tetrahydropyridine 3,4-disubstituee
CN1780663A (zh) * 2003-04-30 2006-05-31 埃科特莱茵药品有限公司 作为肾素抑制剂的新型3－位具有杂原子的9－氮杂双环壬烯衍生物
KR20060006069A (ko) * 2003-04-30 2006-01-18 액테리온 파마슈티칼 리미티드 아자비사이클로노넨 유도체
JP2006524657A (ja) * 2003-04-30 2006-11-02 アクテリオン　ファマシューティカルズ　リミテッド 新規トロパン誘導体
RU2005137571A (ru) * 2003-05-02 2006-05-10 Актелион Фармасьютикалз Лтд. (Ch) Новые производные диазабициклононена
DE602004021206D1 (de) * 2003-07-24 2009-07-02 Euro Celtique Sa Zur Behandlung oder Vorbeugung von Schmerzen geeignete Heteroaryl-Tetrahydropiperidyl-Verbindungen
TW200513461A (en) 2003-10-01 2005-04-16 Speedel Experimenta Ag Organische verbindungen
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
US20070135405A1 (en) * 2003-10-23 2007-06-14 Olivier Bezencon Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain
KR20060120146A (ko) 2003-11-26 2006-11-24 노파르티스 아게 레닌 억제제로서의 4-페닐피페리딘 유도체
NZ549535A (en) 2004-03-17 2010-11-26 Novartis Ag Use of aliskiren for treating renal and other disorders
JP2007223901A (ja) * 2004-03-24 2007-09-06 Takeda Chem Ind Ltd 複素環化合物およびその用途
AR053406A1 (es) * 2004-07-09 2007-05-09 Speedel Experimenta Ag Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas
CN101010323B (zh) 2004-08-25 2010-06-16 埃科特莱茵药品有限公司 作为肾素抑制剂的双环壬烯衍生物
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
ATE514697T1 (de) * 2005-01-28 2011-07-15 Actelion Pharmaceuticals Ltd 7-ä4-ä2-(2,6-dichloro-4- methylphenoxy)ethoxyüphenylü-3,9- diazabicycloä3.3.1ünon-6-ene-6-carbonsäure- cyclopropyl-(2,3-dimethylbenzyl)amid als renin- hemmer für die behandlung von bluthochdruck
TW200722424A (en) 2005-03-31 2007-06-16 Speedel Experimenta Ag Substituted piperidines
EP1897879A3 (fr) 2005-03-31 2008-06-11 Speedel Experimenta AG Pipéridines 2,4,5-substituées comme inhibiteurs de la rénine
US20090270380A1 (en) * 2005-03-31 2009-10-29 Peter Herold 3,4,5-Substituted Piperidines as Renin Inhibitors
EP1707202A1 (fr) * 2005-03-31 2006-10-04 Speedel Experimenta AG Composes organiques
ES2352564T3 (es) * 2005-03-31 2011-02-21 Novartis Ag Piperidinas sustituidas.
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines
GB0508992D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
GB0510810D0 (en) * 2005-05-26 2005-06-29 Novartis Ag Organic compounds
GEP20115206B (en) 2005-05-27 2011-04-26 Actelion Pharmaceuticals Ltd Novel piperidine carboxylic acid amide derivatives
WO2006131884A2 (fr) * 2005-06-07 2006-12-14 Actelion Pharmaceuticals Ltd Nouveaux derives de thiazole
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
KR101020351B1 (ko) 2005-07-29 2011-03-08 에프. 호프만-라 로슈 아게 인돌-3-일-카본일-피페리딘 및 피페라진 유도체
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
EP2420491B1 (fr) 2005-12-30 2013-07-03 Novartis AG Dérivés de pipéridine 3,5-substitués en tant qu'inhibiteurs de rénine
EP1816122A3 (fr) * 2006-01-19 2007-09-19 Speedel Experimenta AG Pipéridines substituées 3,4,5 en tant que composants thérapeutiques
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
RU2425032C2 (ru) 2006-02-02 2011-07-27 Актелион Фармасьютикалз Лтд Вторичные амины в качестве ингибиторов ренина
WO2007120523A2 (fr) * 2006-03-31 2007-10-25 Vitae Pharmaceuticals, Inc. 6-(aminoalkyl)indazoles
JP5420398B2 (ja) 2006-05-19 2014-02-19 アッヴィ・バハマズ・リミテッド Ｃｎｓ活性縮合ビシクロ複素環置換アザ二環式アルカン誘導体
TW200815425A (en) 2006-06-08 2008-04-01 Speedel Experimenta Ag 2,5-disubstituted piperidines
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EP2097377B1 (fr) * 2006-11-17 2010-07-07 Merck Frosst Canada Ltd. Inhibiteurs de la rénine
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP1987834A3 (fr) 2007-02-13 2008-11-19 Speedel Experimenta AG Pipéridines substituées en tant que composants thérapeutiques
WO2008128889A1 (fr) * 2007-04-19 2008-10-30 F. Hoffmann-La Roche Ag Dérivés du dihydro-benzo[b][1,4]diazépine-2-one sulfamide
NZ580266A (en) * 2007-04-27 2012-03-30 Purdue Pharma Lp Trpv1 inhibitors / antagonists and uses thereof
EP2181105B1 (fr) 2007-06-25 2015-04-29 Novartis AG Derives de n5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide utiles comme inhibiteurs de renine
CA2693169C (fr) 2007-07-19 2016-01-12 Metabolex, Inc. Agonistes de recepteur heterocyclique a liaison n pour le traitement du diabete et des troubles metaboliques
EP2018862A1 (fr) 2007-07-25 2009-01-28 Speedel Experimenta AG Pipéridines substituées en tant que composants thérapeutiques
TW200927101A (en) 2007-10-18 2009-07-01 Speedel Experimenta Ag Trisubstituted piperidines
TW200922596A (en) * 2007-10-25 2009-06-01 Speedel Experimenta Ag 4,4-disubstituted piperidines
KR20100075590A (ko) * 2007-11-02 2010-07-02 노파르티스 아게 레닌 억제제로서의 4,4-이치환된 피페리딘
TW200932241A (en) 2007-12-05 2009-08-01 Speedel Experimenta Ag Organic compounds
WO2009106599A2 (fr) * 2008-02-29 2009-09-03 Novartis Ag Pipéridines substituées en tant que composés thérapeutiques
KR20100134659A (ko) * 2008-03-31 2010-12-23 메타볼렉스, 인코포레이티드 옥시메틸렌 아릴 화합물 및 그것의 사용
JP4790871B2 (ja) 2008-05-05 2011-10-12 メルク フロスト カナダ リミテツド レニン阻害剤としての３，４−置換ピペリジン誘導体
KR20110026481A (ko) * 2008-06-20 2011-03-15 메타볼렉스, 인코포레이티드 아릴 ｇｐｒ１１９ 작동약 및 이의 용도
JPWO2010013849A1 (ja) 2008-08-01 2012-01-12 日本ケミファ株式会社 Ｇｐｒ１１９作動薬
EP2163245A1 (fr) 2008-09-10 2010-03-17 Novartis Ag Inhibiteurs de la rénine pour le traitement du psoriasis
JP2010090110A (ja) * 2008-09-12 2010-04-22 Sumitomo Chemical Co Ltd Ｎ−置換−トランス−４−アジドピペリジン−３−オールの製造方法
EP2376473A4 (fr) * 2008-12-10 2012-05-02 Merck Canada Inc Dérivés de pipéridine à substitution en 3,4 utilisés comme inhibiteurs de rénine
EP2421828A2 (fr) 2009-04-24 2012-02-29 Cadila Healthcare Limited Derivatifs de piperidine comme inhibiteurs de rénine
WO2011030139A1 (fr) 2009-09-11 2011-03-17 Astrazeneca Ab Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119
WO2011041154A1 (fr) * 2009-10-01 2011-04-07 Metabolex, Inc. Sels de la tétrazol-1-yl-phénoxyméthyl-thiazol-2-yl-pipéridinyl-pyrimidine substituée
CN109674753A (zh) 2010-06-23 2019-04-26 希玛贝治疗股份有限公司 固态分散体
US20120184572A1 (en) * 2011-01-13 2012-07-19 Metabolex, Inc. Aryl gpr119 agonists and uses thereof
KR20150055094A (ko) 2011-06-22 2015-05-20 퍼듀 퍼머 엘피 디히드록시 치환기를 포함하는 trpv1 길항제 및 그의 용도
WO2013088452A2 (fr) 2011-11-11 2013-06-20 Sun Pharma Advanced Research Company Ltd. Dérivés de quinoléine utilisés en tant qu'inhibiteurs de la rénine
WO2013084241A1 (fr) 2011-12-09 2013-06-13 Cadila Healthcare Limited Composés inhibiteurs de rénine
CN104370813A (zh) * 2014-10-22 2015-02-25 上海大学 异喹啉-6-甲醛的制备方法
US10292983B2 (en) 2016-08-03 2019-05-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN110041212B (zh) * 2019-05-21 2020-10-02 吉林大学 一种含氟多胺单体及其制备方法、一种聚酰亚胺及其制备方法和一种聚酰亚胺膜
CN119059990B (zh) * 2024-11-01 2025-02-07 安徽昊帆生物有限公司 1-氨基甲酸叔丁酯哌嗪的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545792B2 (de) * 1965-02-27 1975-08-07 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 4-Hydroxyplperidinen
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives

Also Published As

Publication number Publication date
BR9610385A (pt) 1999-07-06
CZ68498A3 (cs) 1998-10-14
ATE242213T1 (de) 2003-06-15
TR199800409T1 (xx) 1998-05-21
AU6743296A (en) 1997-03-27
US6051712A (en) 2000-04-18
ES2201192T3 (es) 2004-03-16
HUP9900926A2 (hu) 1999-09-28
MY121967A (en) 2006-03-31
CN1256326C (zh) 2006-05-17
NO980954D0 (no) 1998-03-05
PL193686B1 (pl) 2007-03-30
SA96170317B1 (ar) 2006-05-13
TW474932B (en) 2002-02-01
IL123293A0 (en) 1998-09-24
PT863875E (pt) 2003-10-31
EP0863875A1 (fr) 1998-09-16
CY2488B1 (en) 2005-06-03
RU2167865C2 (ru) 2001-05-27
NO980954L (no) 1998-04-28
AU708616B2 (en) 1999-08-05
JP3648251B2 (ja) 2005-05-18
KR19990044459A (ko) 1999-06-25
EP0863875B1 (fr) 2003-06-04
KR100384979B1 (ko) 2003-10-17
DK0863875T3 (da) 2003-12-01
CN1202152A (zh) 1998-12-16
NZ315677A (en) 2000-02-28
HUP9900926A3 (en) 2002-12-28
US6150526A (en) 2000-11-21
DE59610509D1 (de) 2003-07-10
CA2230931C (fr) 2009-05-19
WO1997009311A1 (fr) 1997-03-13
NO310069B1 (no) 2001-05-14
MX9801814A (es) 1998-08-30
CA2230931A1 (fr) 1997-03-13
JPH11500447A (ja) 1999-01-12
HK1016177A1 (en) 1999-10-29
CZ292327B6 (cs) 2003-09-17
PL325425A1 (en) 1998-07-20
MA23967A1 (fr) 1997-04-01

Similar Documents

Publication Publication Date Title
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
CA2243504A1 (fr) Nouveaux derives de 19-nor-pregnene
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
MY106280A (en) Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use.
CA2425560A1 (fr) Nouveaux anticholinergiques, leurs procedes de production et leur utilisation en tant que compositions pharmaceutiques
CA2259621A1 (fr) Derives d'isocoumarine et utilisation de ces derniers dans des medicaments
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
IL114833A (en) Anthracyclinone derivatives for use as medicaments or for the manufacture of a medicament and pharmaceutical compositions comprising said derivatives for the treatment of amyloidosis, some such derivatives and processes for their preparation
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
CA2176144A1 (fr) Derives d'anthracycline pour le traitement des amyloses
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
NZ243784A (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkane derivatives and pharmaceutical compositions
GEP20002271B (en) Bicyclic Tachykinins Antagonists, Pharmaceutical Composition on Its Basis and Their Use
GR3023941T3 (en) Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees